TY - JOUR
T1 - A retrospective analysis of diagnostic testing in a large North American cohort of patients with epidermolysis bullosa
AU - Phillips, Gregory Scott
AU - Huang, Amy
AU - Augsburger, Bret D.
AU - Kaplan, Laura
AU - Peoples, Kathleen
AU - Bruckner, Anna L.
AU - Khuu, Phuong
AU - Tang, Jean Y.
AU - Lara-Corrales, Irene
AU - Pope, Elena
AU - Wiss, Karen
AU - Levin, Laura E.
AU - Morel, Kimberly D.
AU - Hook, Kristen P.
AU - Paller, Amy S.
AU - Eichenfield, Lawrence F.
AU - McCuaig, Catherine C.
AU - Powell, Julie
AU - Castelo-Soccio, Leslie
AU - Levy, Moise L.
AU - Price, Harper N.
AU - Schachner, Lawrence A.
AU - Browning, John C.
AU - Jahnke, Marla
AU - Shwayder, Tor
AU - Bayliss, Susan
AU - Lucky, Anne W.
AU - Glick, Sharon A.
N1 - Publisher Copyright:
© 2021 American Academy of Dermatology, Inc.
PY - 2022/5
Y1 - 2022/5
N2 - Background: Accurate diagnosis of epidermolysis bullosa (EB) has significant implications for prognosis, management, and genetic counseling. Objective: To describe diagnostic testing patterns and assess diagnostic concordance of transmission electron microscopy (TEM), immunofluorescence mapping (IFM), and genetic analysis for EB. Methods: A retrospective cohort included patients enrolled in the Epidermolysis Bullosa Clinical Characterization and Outcomes Database from January 1, 2004, to July 8, 2019. Tests concluding the same EB type (EB simplex, junctional EB, dominant dystrophic EB, and recessive dystrophic EB) were considered concordant; those concluding different EB types were considered discordant; and those with nonspecific/nondefinitive results were equivocal. Results: A total of 970 diagnostic tests were conducted from 1984 to 2018 in 771 patients. Genetic analyses were performed chronologically later than IFM or TEM (P <.001). The likelihood of undergoing genetic analysis was greater for junctional EB and recessive dystrophic EB, and the same for dominant dystrophic EB as compared with EB simplex. TEM results in 163 patients were equivocal (55%), concordant (42%), and discordant (3%). IFM results in 185 patients were equivocal (54%), concordant (42%), and discordant (4%). Limitations: Retrospective design. Conclusions: Diagnostic testing has shifted in favor of genetic analysis. TEM and IFM frequently offer equivocal findings when compared to the specificity afforded by genetic analysis.
AB - Background: Accurate diagnosis of epidermolysis bullosa (EB) has significant implications for prognosis, management, and genetic counseling. Objective: To describe diagnostic testing patterns and assess diagnostic concordance of transmission electron microscopy (TEM), immunofluorescence mapping (IFM), and genetic analysis for EB. Methods: A retrospective cohort included patients enrolled in the Epidermolysis Bullosa Clinical Characterization and Outcomes Database from January 1, 2004, to July 8, 2019. Tests concluding the same EB type (EB simplex, junctional EB, dominant dystrophic EB, and recessive dystrophic EB) were considered concordant; those concluding different EB types were considered discordant; and those with nonspecific/nondefinitive results were equivocal. Results: A total of 970 diagnostic tests were conducted from 1984 to 2018 in 771 patients. Genetic analyses were performed chronologically later than IFM or TEM (P <.001). The likelihood of undergoing genetic analysis was greater for junctional EB and recessive dystrophic EB, and the same for dominant dystrophic EB as compared with EB simplex. TEM results in 163 patients were equivocal (55%), concordant (42%), and discordant (3%). IFM results in 185 patients were equivocal (54%), concordant (42%), and discordant (4%). Limitations: Retrospective design. Conclusions: Diagnostic testing has shifted in favor of genetic analysis. TEM and IFM frequently offer equivocal findings when compared to the specificity afforded by genetic analysis.
KW - diagnostic concordance
KW - diagnostic testing
KW - electron microscopy
KW - epidermolysis bullosa
KW - genetic analysis
KW - genetics
KW - immunofluorescence mapping
KW - laboratory testing
KW - next-generation sequencing
UR - http://www.scopus.com/inward/record.url?scp=85118256386&partnerID=8YFLogxK
UR - http://www.scopus.com/inward/citedby.url?scp=85118256386&partnerID=8YFLogxK
U2 - 10.1016/j.jaad.2021.09.065
DO - 10.1016/j.jaad.2021.09.065
M3 - Article
C2 - 34634382
AN - SCOPUS:85118256386
SN - 0190-9622
VL - 86
SP - 1063
EP - 1071
JO - Journal of the American Academy of Dermatology
JF - Journal of the American Academy of Dermatology
IS - 5
ER -